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RATIONALE: CaMKII (Ca2+-Calmodulin dependent protein kinase) δC activation is implicated in pathological progression of 
heart failure (HF) and CaMKIIδC transgenic mice rapidly develop HF and arrhythmias. However, little is known about early 
spatio-temporal Ca2+ handling and CaMKII activation in hypertrophy and HF.
OBJECTIVE: To measure time- and location-dependent activation of CaMKIIδC signaling in adult ventricular cardiomyocytes, 
during transaortic constriction (TAC) and in CaMKIIδC transgenic mice.
METHODS AND RESULTS: We used human tissue from nonfailing and HF hearts, 4 mouse lines: wild-type, KO (CaMKIIδ-
knockout), CaMKIIδC transgenic in wild-type (TG), or KO background, and wild-type mice exposed to TAC. Confocal imaging 
and biochemistry revealed disproportional CaMKIIδC activation and accumulation in nuclear and perinuclear versus cytosolic 
regions at 5 days post-TAC. This CaMKIIδ activation caused a compensatory increase in sarcoplasmic reticulum Ca2+ content, 
Ca2+ transient amplitude, and [Ca2+] decline rates, with reduced phospholamban expression, all of which were most prominent 
near and in the nucleus. These early adaptive effects in TAC were entirely mimicked in young CaMKIIδ TG mice (6–8 weeks) 
where no overt cardiac dysfunction was present. The (peri)nuclear CaMKII accumulation also correlated with enhanced 
HDAC4 (histone deacetylase) nuclear export, creating a microdomain for transcriptional regulation. At longer times both 
TAC and TG mice progressed to overt HF (at 45 days and 11–13 weeks, respectively), during which time the compensatory 
Ca2+ transient effects reversed, but further increases in nuclear and time-averaged [Ca2+] and CaMKII activation occurred. 
CaMKIIδ TG mice lacking δB exhibited more severe HF, eccentric myocyte growth, and nuclear changes. Patient HF samples 
also showed greatly increased CaMKIIδ expression, especially for CaMKIIδC in nuclear fractions.
CONCLUSIONS: We conclude that in early TAC perinuclear CaMKIIδC activation promotes adaptive increases in myocyte Ca2+ 
transients and nuclear transcriptional responses but that chronic progression of this nuclear Ca2+-CaMKIIδC axis contributes 
to eccentric hypertrophy and HF.
GRAPHIC ABSTRACT: A graphic abstract is available for this article.
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Development of hypertrophy and its progression to heart failure (HF) is characterized by altered cardio-myocyte Ca2+, excitation-contraction coupling (ECC), 
and the activation of multiple Ca2+-linked hypertrophic 
signaling pathways, a process referred to as excitation-
transcription coupling (ETC).1,2 Better understanding of the 
mechanisms leading to abnormal Ca2+ cycling in pathol-
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At each beat, the cytosolic Ca2+ transient (CaT) that 
drives cardiomyocyte contraction and relaxation also 
drives nuclear CaT.3 However, the nuclear envelope (NE) 
slows the kinetics and reduces the amplitude of nucleo-
plasmic versus cytoplasmic CaT. Indeed, normally nuclear 
CaTs appear to depend mainly on Ca2+ diffusion into and 
out of the nucleus via nuclear pores, with most sarcoplas-
mic reticulum (SR) Ca2+ release and reuptake occurring 
outside the nucleus.4 Abnormal myocyte Ca2+ handling 
may be an early event in myocardial remodeling, and sig-
naling via CaMKII (Ca2+-Calmodulin dependent protein 
kinase) has been shown to alter both cytosolic ECC and 
nuclear ETC1,5 The slower nuclear [Ca2+] ([Ca]Nuc) decline 
Nonstandard Abbreviations and Acronyms
[Ca]Cyto cytoplasmic [Ca2+]
[Ca]Nuc nuclear [Ca2+]













KO-δCTG CaMKIIδC transgenic in KO background
NE nuclear envelope
PKA protein kinase A
PKD protein kinase D
Novelty and Significance
What Is Known?
• Transcriptional changes and reactivation of fetal gene 
programs are hallmark of hypertrophic cardiac remod-
eling and progression to heart failure.
• CaMKII (Ca2+-Calmodulin dependent protein kinase) is 
a nodal regulator of diverse acute and long-term sig-
naling to downstream cellular targets.
• CaMKII activation is implicated in heart failure pro-
gression and transgenic overexpression of cardiac 
CaMKIIδC rapidly induces heart failure and arrhythmias.
What New Information Does This Article  
Contribute?
• Using multiple mouse models to study early cardiac 
hypertrophy we found disproportional CaMKIIδ acti-
vation in the nuclear and perinuclear versus cytosolic 
region.
• Early in pressure overload (transaortic constriction) and 
CaMKIIδC overexpression, perinuclear CaMKII activa-
tion enhanced Ca2+ cycling and sarcoplasmic reticu-
lum Ca2+ uptake as an adaptive response to pressure 
overload.
• Later, chronic CaMKIIδC activation leads to its nuclear 
accumulation and drives maladaptive transcriptional 
effects, eccentric cardiac hypertrophy, and progression 
to heart failure.
The hypertrophied and failing heart exhibits abnormali-
ties in signal transduction systems, and CaMKIIδ has 
emerged as a key nodal promoter of cardiac remod-
eling. This article provides new mechanistic insight 
into how isoform-specific CaMKIIδ activation can 
drive early adaptive Ca2+ handling changes to help 
meet hemodynamic demands while also causing later 
maladaptive cardiac alterations. While CaMKIIδ post-
translational modifications in the regulatory domain 
have been identified and associated with various car-
diac pathologies, here we describe, for the first time 
that (peri)nuclear accumulation of activated CaMKIIδC 
is a critical step in the development and progression of 
eccentric cardiac growth. Also, we provide first func-
tional evidence that perinuclear region is a fine-tuned 
microdomain for transcriptional regulation serving as 
a local pool of Ca2+-dependent transcription factors 
that are poised for shuttling in and out of the nucleus 
when local [Ca2+] is elevated. Importantly, using human 
tissue from nonfailing and failing hearts we showed 
that these findings extend to humans and may have 
clinical relevance. This may open new avenues for 
therapeutic strategies that can—by acting on a subset 
of downstream targets—improve efficacy and minimize 
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causes progressive elevation of diastolic [Ca]Nuc at higher 
pacing rates and this elevated [Ca]Nuc is exacerbated in 
HF, in part because of altered nuclear structure and 
nuclear pore location.4 This makes nuclear Ca2+ handling 
of particular interest for Ca2+-dependent ETC and altered 
protein expression in the progression of hypertrophy and 
its transition to HF. Yet, there is a need for more detailed 
information as to how nuclear versus cytosolic CaMKIIδ 
(the predominant cardiac isoform) gets activated dur-
ing the progression toward HF and how that modulates 
HDAC (histone deacetylase) nuclear export which regu-
lates transcription.
Two key CaMKIIδ splice variants, CaMKIIδB and 
CaMKIIδC, differ by only an 11 amino acid nuclear local-
ization signal in the former. While CaMKIIδB tends to 
be more nuclear than CaMKIIδC, both variants exist in 
nucleus and cytosol6 and were found to be remarkably 
mobile within the myocyte, especially upon activation.7 
Acute CaMKIIδC effects are mediated by direct modu-
lation of non-nuclear proteins, such as RyRs (ryanodine 
receptors), L-type Ca2+ channels, PLB (phospholam-
ban), ion channels, and myofilaments, to mediate con-
tractile dysfunction and arrhythmogenesis.5 Conversely, 
CaMKIIδB is thought to control transcriptional CaMKII 
effects on gene-regulating proteins (eg, HDACs). But 
detailed examination of CaMKIIδ localization revealed 
more spatial overlap and that CaMKIIδC is more patho-
logical, while CaMKIIδB may restrain the negative effects 
of CaMKIIδC.6,8
Here, we used 4 mouse lines: wild-type (WT), 
CaMKIIδC transgenic (TG), KO (CaMKIIδ-knockout), or 
CaMKIIδC transgenic in the KO background (KO-δCTG). 
We also exposed WT mice to transaortic constriction 
(TAC) to study early hypertrophy and HF, stages where 
CaMKIIδ expression and activation are elevated. We 
found overproportional CaMKII activation in the nuclear 
and perinuclear versus cytosolic region. Notably, these 
effects were mainly due to CaMKIIδC and not the 
more nuclear CaMKIIδB and correlated with effects 
on HDAC4 nuclear export. Human samples confirmed 
the more prominent nuclear CaMKIIδC expression in 
HF. Moreover, we found that nuclear CaMKIIδC activa-
tion and HDAC4 nuclear export were already apparent 
in both young CaMKIIδC-TG and TAC mice far before 
signs of HF were evident. Finally, elevated CaMKIIδC 
promoted eccentric cardiac growth, leading to acceler-
ated chamber dilation, without adaptive hypertrophy of 
the ventricular wall. Thus, we provide clear evidence for 
early activation of the CaMKIIδC axis during TAC and 
subsequent CaMKIIδC-dependent enhancement of 
nuclear Ca2+ signaling which further promotes the acti-
vation and (peri)nuclear accumulation of CaMKIIδC. The 
autoreinforcing property of CaMKIIδC signaling may be 
critical in the progression from hypertrophy to HF via the 
interplay of ECC and ETC.
METHODS
The data supporting findings of this study are available from 
the corresponding author upon reasonable request. Materials 
and methods are described in detail in the Data Supplement. All 
essential research materials are listed in the Major Resources 
Table in the Data Supplement.
All procedures involving animals adhered to the National 
Institutes of Health Guide for the Care and Use of Laboratory 
Animals (UC Davis) or the Federal Act on the Protection of 
Animals (Medical University of Graz) and were approved by the 
Institutional Animal Care and Use Committee. Human sample use 
was approved by the Ethical Committee of the Medical University 
of Graz and was carried out in accordance with the Declaration of 
Helsinki. Patient characteristics are summarized in Table I.
RESULTS
Larger Cytoplasmic and Nuclear CaTs Early in 
TAC Are CaMKII-Dependent
Fluo-4 fluorescence signals recorded during electrical 
stimulation were transformed into cytoplasmic [Ca2+] 
([Ca]Cyto; black) and [Ca]Nuc (red) using our compartment-
specific calibration methods (Figure 1A).9,10 Sham-
operated mice showed no statistical differences in CaTs 
between the 5- and 45-day groups and were pooled as 
one control group (for details on cardiac function see 
Table V in the Data Supplement). Early post-TAC (5 days) 
diastolic [Ca]Cyto was reduced, but [Ca]Nuc was unaltered 
(Figure 1B and 1D). CaT amplitudes were significantly 
increased (Δ[Ca]Cyto by ≈45% and Δ[Ca]Nuc by ≈80%; 
Figure 1C). Kinetics of both [Ca]Cyto and [Ca]Nuc decay 
were faster early in hypertrophy (Figure 1E), likely indi-
cating faster SR Ca2+ uptake. Time to peak [Ca]Nuc (but 
not [Ca]Cyto) was also shorter in early TAC (Figure 1F). 
Notably, the rise in CaT amplitude was more pronounced 
in the nucleus than cytosol (larger % change). We sug-
gest that these early changes are mediated by enhanced 
SR Ca2+ uptake and release, as a compensation for the 
TAC-imposed afterload.
At the later HF stage (45 days post-TAC),4 the dia-
stolic [Ca] was elevated, and CaT amplitude was reduced 
in both cytosol and nucleus (Figure 1B through 1D), 
and the rate of [Ca] decline was slowed (Figure 1E). 
This is typical of CaT changes in HF.4 Notably, the 
early phenotype in TAC-operated mice was associated 
already with persistent CaMKII activation, especially 
around NE (Figure 1G) and acute CaMKII inhibition 
by N-[2-[[[(E)-3-(4-chlorophenyl)prop-2-enyl]-methyl-
amino]methyl]phenyl]-N-(2-hydroxyethyl)-4-methoxy-
benzenesulfonamide (KN-93; Figure 1H and 1I), but 
not 2-[N-(4’-Methoxybenzenesulfonyl)]amino-N-(4’-
chlorophenyl)-2-propenyl-N-methylbenzylamine phos-
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Figure 1. Characterization of cytoplasmic and nucleoplasmic [Ca2+] transients (CaTs) after pressure overload–induced 
hypertrophy and heart failure in mouse ventricular myocytes.
A, Averaged original recordings of electrically stimulated CaTs in the nucleus (red) vs cytoplasm (black) of cardiomyocytes from sham-operated 
mice (left) and from mice subjected to transaortic constriction (TAC) isolated 5 (middle) and 45 d (right) after intervention. B, Calibrated 
diastolic (Dia) [Ca2+] and (C) amplitude of nucleoplasmic (red) and cytoplasmic (black) CaTs. D, Diastolic (Dia) [Ca2+] corresponding to the global 
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Young CaMKIIδC Transgenic Mice Exhibit CaT 
Changes Like Those in Early TAC
Because mice transgenic for CaMKIIδC spontaneously 
develop hypertrophy and HF, we tested whether the 
TAC-induced changes were recapitulated in CaMKIIδC 
transgenic (TG) mice (Figure 2). Exactly as in early TAC, 
the 6- to 8-week CaMKIIδC-TG versus WT myocytes 
had lower diastolic [Ca]Cyto, larger CaT amplitudes in 
cytosol and nucleus, and faster [Ca] decline in both 
compartments (Figure 2B through 2F). Also, as in early 
TAC, the percentage rise in [Ca]Nuc CaTs was higher 
than that for [Ca]Cyto in young TG myocytes versus WT. 
Conversely, in KO versus WT myocytes diastolic [Ca]Cyto 
and [Ca]Nuc were slightly elevated, Δ[Ca]Nuc was lower, 
and the decay of [Ca]Cyto was slower. We conclude that 
at this early stage (like early TAC), CaMKIIδC overex-
pression elevates CaT amplitudes, and SR Ca2+ uptake 
mediated [Ca]Cyto decline. The KO versus WT results 
also suggest that even in WT a low level of CaMKIIδ-
dependent SERCA (SR Ca2+-ATPase) activation may 
promote larger and faster CaTs and limit diastolic 
[Ca]Cyto and [Ca]Nuc.
A recent study by Baier et al11 showed that excessive 
CaMKII inactivation in AC3-I (autocamtide-3-derived 
inhibitory peptide) transgenic mice impairs adaptation 
of ECC in early pressure-induced overload. Specifically, 
AC3-I transgenic mice fail to increase CaTs within 2 to 
5 days after TAC, leading to diminished cardiac func-
tion and premature death, demonstrating that CaMKII 
activation is a pivotal part of cardiac stress physiology. 
To further test our finding that CaMKIIδC is exclusively 
responsible for early compensatory response, we mea-
sured CaTs from young CaMKIIδ transgenic mice with 
the genetic deletion of CaMKIIδ (KO-δCTG, Figure 
II in the Data Supplement). We found that 6-week-old 
KO-δCTG mice had increased CaTs and nucleoplasmic 
Ca2+ signaling, which resembled that of TG mice at the 
age between 6 and 8 weeks. Interestingly, we found a 
prominent reduction in nucleoplasmic but not cytoplas-
mic CaTs in 8-week-old KO-δCTG mice versus 6-week-
old mice. This indicates that (1) KO-δCTG mice display 
accelerated remodeling as compared to TG mice, despite 
comparable CaMKII expression levels (Figure IIIA in the 
Data Supplement) and, (2) that CaMKIIδC causes Ca2+-
perturbations in the nucleus earlier than in the cytoplasm.
As the CaMKIIδC-TG (CaMKIIδC transgenic 
mice) mice progress toward HF at 11 to 3 weeks of 
age, the CaT situation changes dramatically. At 11 to 13 
weeks, TG mice (versus WT) have highly elevated dia-
stolic [Ca]Cyto and [Ca]Nuc, and slowed CaTs kinetics in 
both compartments, consistent with advanced remodel-
ing with reprogrammed protein pattern. The [Ca]Nuc tran-
sient amplitude was greatly reduced, both versus WT 
and the 6- to 8-week data, but these nuclear CaTs were 
riding on a very large diastolic [Ca]Nuc, such that peak 
[Ca]Nuc was above the WT, and time-averaged [Ca]Nuc was 
highly elevated (Figure 2B). The cytosolic CaT amplitude 
in 11- to 13-week TG mice was greatly reduced from 
that at 6 to 8 weeks but was still comparable to the 
WT Δ[Ca]Cyto. That differs from our early CaMKIIδC-TG 
mouse study in 2003,12,13 where a ≈50% reduction in 
cytosolic CaT amplitude was seen at 12 weeks of age 
(and mice exhibited overt HF with nearly 50% mortality). 
However, it agrees with more recent studies in this TG 
line (2014)14 where we found milder and delayed HF 
onset, with mortality beginning at 15 weeks. Thus, we 
infer that the 11- to 13-week TG mice in the present 
study are only at the onset of decompensating HF. Many 
disease-causing genetically modified mice develop less 
severe phenotype after many generations. It is not fully 
understood why, but one possibility is that it reflects a 
simple selective advantage of offspring that can better 
adapt to stresses, thereby limiting the strength of dis-
ease penetrance in subsequent generations.15
Increased SR Ca2+ Load and SERCA2/PLB 
Expression in Early TAC and Young CaMKIIδC 
Transgenic Mice
We next tested whether the faster [Ca] decline and 
elevated CaT amplitudes seen in early TAC and young 
CaMKIIδC-TG mice occurred with elevated SR Ca2+ 
content and whether it might be mediated by altered 
expression of SERCA2 and PLB. Figure 3A shows rapid 
caffeine-induced CaTs used to assess SR Ca2+ content, 
which was higher in early TAC mice whether measured 
in the cytosol or nucleus (Figure 2B). Fluo-4 is a high-
affinity Ca2+ dye and caffeine-induced CaTs can reach the 
shallow nonlinear part of the calibration curve. Hence, we 
did not calibrate these values. The TAC-induced rise in SR 
Ca2+ load (ΔF) was larger in the nucleus versus cytosol 
(Figure 3B, right). The time constant of cytosolic [Ca2+]i 
decline during the caffeine-induced Ca2+ transients was 
not statistically different between sham and 5-day TAC 
Figure 1 Continued. (F) time to peak. G, Original confocal images (left) of cardiomyocytes from sham-operated and TAC-operated mice (5 and 
45 d after intervention) immunostained for P-CaMKII (phospho-Ca2+-Calmodulin dependent protein kinase) and average P-CaMKII fluorescence 
values (right) in nucleus vs cytoplasm. H, Averaged original recordings of electrically stimulated CaTs in the nucleus (red) vs cytoplasm (black) 
of cardiomyocytes from sham-operated (left) and TAC-operated mice in the absence (middle) and presence (right) of CaMKII inhibitor N-[2-
[[[(E)-3-(4-chlorophenyl)prop-2-enyl]-methylamino]methyl]phenyl]-N-(2-hydroxyethyl)-4-methoxybenzenesulfonamide (KN-93). I, Corresponding 
calibrated amplitude of nucleoplasmic (red) and cytoplasmic (black) CaTs. B through F, n=10–15 myocytes per group. G–I, n=10–20 myocytes 
per group. P values were calculated using Mann-Whitney test comparing TAC, 45 d, or KN-93 to the respective control (B–F; I) or Kruskal-Wallis 
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(3.73±0.19 versus 3.75±0.21), suggesting unaltered Na+/
Ca2+ exchange function at this early stage of hypertrophy.
We also analyzed the expression and activation of 
the key SR Ca2+ uptake proteins (SERCA2 and PLB) in 
left ventricular tissue lysates and isolated cardiomyocyte 
nuclei from control and TAC-operated mice 5 days post-
TAC. SERCA2 levels were not significantly altered in 
either lysates or isolated nuclei at this stage, but PLB 
was significantly downregulated at 5 days post-TAC, 
whereas its phosphorylation was increased, resulting in 
Figure 2. Characterization of cytoplasmic and nucleoplasmic [Ca2+] transients (CaTs) in electrically stimulated ventricular 
myocytes isolated from 6- to 8-wk and 11- to 13-wk old CaMKIIδ-KO (Ca2+-Calmodulin dependent protein kinase δ knock out), 
wild-type (WT) and CaMKIIδC-TG mice.
A, Linescan imaging of cytoplasmic and nucleoplasmic CaTs in a cardiomyocyte. B, Averaged original recordings of distinct subcellular regions, as 
indicated in A: nucleus (red) vs cytoplasm (black) of cardiomyocytes from WT (left), CaMKIIδ-KO (KO, middle), and CaMKIIδC overexpressing 
mice (TG, right), isolated 6–8 or 11–13 wk after intervention. Diastolic (Dia) [Ca2+] (C), amplitude (D), time to peak (E) and time from peak [Ca2+] 
to 50% decline (DT50) of nucleoplasmic (red) and cytoplasmic (black) CaTs. B–E, n=9–14 myocytes per group. P values were calculated using 
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Figure 3. Sarcoplasmic reticulum (SR) and perinuclear Ca2+ load and expression and intracellular distribution of major Ca2+ 
reuptake proteins in cardiac hypertrophy due to the pressure overload or CaMKIIδC (Ca2+-Calmodulin dependent protein kinase 
δC) overexpression.
A, Linescan image from a cardiomyocyte from a transaortic constriction (TAC)–operated mouse isolated 5 d after intervention and corresponding 
normalized nucleoplasmic (nuc, red) and cytoplasmic (cyto, black) fluorescence traces (normalized to resting fluorescence, F/Frest) recorded 
during caffeine application (left). B, average values of caffeine-evoked Ca2+ transient (CaT) amplitude in cytoplasm and nucleoplasm of 
ventricular myocytes from sham and TAC-operated mice and increases in SR and perinuclear Ca2+ load calculated as difference from sham (ΔF, 
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elevated SERCA/PLB expression ratios in both com-
partments (Figure 3C). PLB binds to and decreases SR 
Ca2+-ATPase activity by lowering its Ca2+ sensitivity, so 
the lower SERCA2/PLB ratio is consistent with faster 
SR Ca2+ uptake rates inferred by faster rates of twitch 
[Ca2+] decline. Notably, the rise in SERCA/PLB ratio 
was greater in the nuclear fraction versus heart lysates 
(300% versus 200%).
Figure 3D shows immunocytochemistry, where we 
can directly assess SERCA and PLB in the nuclear and 
cytosolic regions of the myocyte. In sham mice, the PLB 
signal at the NE was much higher than in the SR (con-
sistent with Wu et al16), whereas SERCA levels showed 
no statistical difference between the 2 loci. During early 
TAC, PLB appeared to be especially reduced at the 
NE. This might account, in part, for the relatively strong 
increase in twitch-associated and caffeine-induced CaTs 
at the nucleus (Figures 1C and 3A).
Similar results were obtained with young CaMKIIδC-TG 
mice (Figure 3E and 3F), suggesting that the downreg-
ulation of PLB at the NE may be critical in regulating 
local [Ca2+] in the nuclear region. To the extent that this 
can modulate nuclear Ca2+-dependent nuclear signaling 
and transcription, this process may start early in TAC or 
CaMKIIδC overexpression.
Frequency-Dependent Nucleoplasmic CaTs in 
Young CaMKIIδC Transgenic Mice
We previously showed that in early TAC higher pacing 
frequencies elevate diastolic [Ca]Nuc to a much larger 
extent than diastolic [Ca]Cyto, leading to the activation of 
nuclear CaMKII and HDAC4 nuclear export.4 Here, we 
tested for parallel frequency-dependent responses in 
young CaMKIIδC-TG mice.
Figure 4A shows CaT in 6- to 8-week TG versus 
WT mice. It is apparent in the images (Figure 1A) and 
traces (Figure 4B) that as pacing rate increases [Ca]Nuc 
remains high even during diastole. However, there was 
little difference in frequency-response of WT and young 
TG mice (6–8 weeks) regarding either diastolic [Ca], 
CaT amplitude or decline (for cytosolic and mostly for 
nucleus; Figure 4C and 4D, Figure IV in the Data Supple-
ment), but data were consistent with the lower diastolic, 
faster decay and higher CaT amplitudes for young TG 
versus WT mice as in Figure 2. The most striking dif-
ference for early TG mice versus WT was that the CaT 
amplitudes were much larger (Figure 4D) and 50% 
decline much faster (Figure IV in the Data Supplement) 
in early TG, and the buildup of diastolic [Ca]Nuc was much 
higher than for [Ca]Cyto at any frequency studied. Notably, 
in the 6- to 8-week TG mice, time-averaged [Ca]Nuc (ie, 
the CaT integral/time) was not statistically different from 
WT at 0.5 Hz but was much higher (≈30%) for any higher 
frequency studied (Figure 4E). These differences were 
more modest for [Ca]Cyto in young TG versus WT. This 
would be consistent with the higher perinuclear SERCA 
function in early TG (or TAC) mice from Figure 3, which 
could promote enhanced nuclear Ca2+ signaling to CaM-
KII and HDAC4. Older TG mice (11–13 weeks) show an 
exacerbated rise in the time-averaged [Ca]Nuc, especially 
at higher pacing rates.
CaMKIIδ Activation and (Peri)Nuclear 
Accumulation in Young CaMKIIδC-TG Mice
The data presented so far clearly indicate enhance-
ment of nuclear Ca2+ signaling and alterations in Ca2+ 
cycling in early pressure overload–induced hypertrophy 
and young CaMKIIδC-TG mice. We speculate that this 
suffices to promote Ca2+-dependent hypertrophic gene 
transcription machinery. Thus, we first sought to assess 
local CaMKIIδ activation under conditions where we 
studied [Ca]Cyto and [Ca]Nuc above. We used antibodies 
against CaMKIIδ and P-CaMKII (phospho-CaMKIIδ) to 
assess autonomously active CaMKII. Antibody specificity 
was validated in detail (Figure V in the Data Supplement).
There was little autonomous P-CaMKII evident in sham 
myocytes at rest, and weak staining at low pacing fre-
quency (0.5 Hz) that increased in both cytosol and nucleus 
at higher stimulation frequency (5 Hz) particularly at the 
NE (Figure 5A through 5C). That is reminiscent of the 
rise in [Ca]Nuc and [Ca]Cyto with pacing (Figure 4) and data 
using FRET (fluorescence resonance energy transfer)-
based CaMKII activity reporters.17 Early post-TAC (5 days) 
myocytes showed greater CaMKIIδ activation than sham 
already at 0.5 Hz; however, we found a clear enhance-
ment of P-CaMKII signal on the SR (cytoplasm) and NE 
only (Figure 5B). At higher pacing frequency—in contrast 
to sham hearts—early WT-TAC hearts displayed an exces-
sive CaMKII nuclear import, which resembled that mea-
sured 45 days after TAC (but was also present at 0.5 Hz 
in late TAC). In both TAC groups, P-CaMKII signal esca-
lated dramatically around the NE (ie, even higher than 
Figure 3 Continued. Scale bar=20 μm. C, Western blots (top) and average data (bottom) of SERCA (SR-Ca2+-ATPase), PLB (phospholamban), 
and P-PLB (PLB phosphorylated at Thr17) expression in tissue lysates and isolated cardiomyocyte nuclei from LV tissue of sham and TAC-operated 
mice. GAPDH was used as loading control for tissue lysate samples and H3 as loading control for nuclei samples. N=4 samples per group. D, 
Dual-staining confocal microscopy images with the monoclonal anti-SERCA antibody conjugated with Alexa fluor-594 (top left) and monoclonal 
anti-PLB antibody conjugated with Alexa fluor-488 (bottom left) and nuclear envelope (NE)-to-sarcoplasmic reticulum intensity ratio profiles 
(right) in cardiomyocytes from Sham vs TAC-operated mice isolated 5 d after intervention. n=16–20 myocytes per group. Scale bars=20 μm. E, 
Corresponding analyses of caffeine-evoked CaTs and (F) subcellular expression of PLB in CaMKIIδC transgenic mice (TG). n=10–20 myocytes per 
group. P values were calculated using Mann-Whitney test comparing TAC or TG to the respective control (B–E), or Wilcoxon signed-rank test for 
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Figure 4. Frequency-dependent changes of nucleoplasmic vs cytoplasmic [Ca2+] transients (CaTs) in ventricular mouse myocytes 
induced by transgenic overexpression of CaMKIIδC (Ca2+-Calmodulin dependent protein kinase δC).
A, Linescan confocal images of cytoplasmic (cyto) and nucleoplasmic (nuc) CaTs in a ventricular myocyte isolated at 7 wk of age from wild-type 
(WT; left) and TG (right) mouse. Note that the area of higher fluorescence corresponds to nuclear signal (nuc). Scale bar=15 μm. B, Averaged 
original recordings of electrically stimulated CaTs in the nucleus (red) vs cytoplasm (black) of ventricular myocytes isolated from 6 to 8 (left) or 11 
to 13 (right) wk old WT (top) and TG (bottom) mice during gradual increase of stimulation frequency from 0.5 to 5 Hz. Frequency-dependent 
changes in (C) diastolic [Ca2+] and (D) amplitude of electrically stimulated CaTs in the cytoplasm (gray) vs nucleus (red) of ventricular myocytes 
isolated from WT (left) and 6–8 (middle) or 11–13 (right) wk old TG mice. E, Time-averaged [Ca2+] calculated as time-integral area under 
CaT-time curve over one cycle of cardiomyocytes isolated from WT and 6–8-wk or 11–13-wk old TG mice. C–E, n=8–21 myocytes per group. P 
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inside the nucleus) upon pacing at 5 Hz. This raises the 
possibility that early on in TAC, active CaMKIIδ accumu-
lates in the perinuclear region, where it can preferentially 
phosphorylate local targets. For example, nuclear CaMKII 
can phosphorylate HDAC4, driving nuclear export, but a 
pool of active perinuclear CaMKII may promote rephos-
phorylation of any exported HDAC4 that happens to get 
dephosphorylated after leaving the nucleus. That could 
help keep dephosphorylated HDAC4 from reentering 
the nucleus and reinforce the transcriptional effects of 
CaMKII activation. Indeed, our previous studies proved the 
role of non-nuclear CaMKIIδ in maintaining HDAC4 in the 
cytosol.18 The P-CaMKII signals above were prevented by 
KN-93 preincubation (Figure 1G), confirming the func-
tional role of CaMKII activity in the observed signals.
Figure 5D shows analogous results in young 
CaMKIIδC-TG mice (6–8 weeks), suggesting that the 
CaMKIIδC variant suffices to produce this strong perinu-
clear CaMKII activation. One difference versus TAC was 
that young TG mice showed substantial phosphorylation 
Figure 5. High-pacing frequency-dependent CaMKIIδ (Ca2+-Calmodulin dependent protein kinase δ) phosphorylation and its 
subcellular redistribution in cardiac hypertrophy due to the pressure overload or CaMKIIδC overexpression.
A, Original confocal images of cardiomyocytes from sham-operated (top) and transaortic constriction (TAC)–operated mice (5 and 45 d after 
intervention, middle and bottom, respectively) immunostained for P-CaMKII (phospho-CaMKII) after stimulation at 0.5 (left) or 2, 5, and 10 min 
of stimulation at 5 (right) Hz. B, Average P-CaMKII fluorescence values (arbitrary units, a.u.) in cytoplasm (black), nucleoplasm (dark green), and 
nuclear envelope (NE, light green) of cardiomyocytes from sham-operated and TAC-operated mice isolated 5 and 45 d after intervention, stimulated 
at 0.5 Hz. C, Average P-CaMKII fluorescence values (left) in time-dependent high-pacing protocol and increases in P-CaMKII levels calculated 
as difference from sham (ΔF, right) in cytoplasm (black), nucleoplasm (dark green), and nuclear envelope (NE, light green) of cardiomyocytes 
from sham-operated and TAC-operated mice isolated 5 and 45 d after intervention. D, Corresponding analyses of CaMKII phosphorylation and 
redistribution in 6–8-wk old CaMKIIδC transgenic mice (TG). E, Original confocal images of cardiomyocytes from 6- to 8-wk old CaMKIIδ knockout 
mice with transgenic overexpression of CaMKIIδC (KO [CaMKIIδ-knockout]-TG) immunostained for CaMKIIδ (top left) and P-CaMKII (top right) 
after 5 min stimulation at 0.5 or 5 Hz and corresponding average CaMKIIδ (bottom left) and P-CaMKII (bottom right) fluorescence values 
in cytoplasm (black), nucleoplasm (dark green) and nuclear envelope (NE, light green). F, Original confocal images of isolated ventricular rabbit 
myocytes expressing GFP (green fluorescent protein)-labeled wild-type (WT) CaMKIIδC (WT; left) vs its autophosphorylation-mimetic T287D-
δC-GFP (T287D, right) and corresponding average fluorescence values in cytoplasm (black), nucleoplasm (dark green) and NE (light green). G, 
Original confocal images of cardiomyocytes from 6- to 8-wk old CaMKIIδ knockout mice with transgenic overexpression of CaMKIIδC (KO-TG) 
preincubated with N-[2-[[[(E)-3-(4-chlorophenyl)prop-2-enyl]-methylamino]methyl]phenyl]-N-(2-hydroxyethyl)-4-methoxybenzenesulfonamide 
(KN-93) and immunostained for P-CaMKII after 5 min stimulation at 0.5 or 5 Hz (left) and corresponding average P-CaMKII (right) fluorescence 
values in cytoplasm (black), nucleoplasm (dark green) and NE (light green). B–G, n=20–30 myocytes per group. P values were calculated using 
Kruskal-Wallis with Dunn post hoc test (B) or Mann-Whitney test comparing 45 d, 5 Hz, or T287D to the respective control (C–G). Scale bars=20 
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of cytosolic CaMKII even at low frequency (black bars 
in Figure 5D versus 5B), which may be in part due to 
the higher absolute levels of CaMKIIδ present in the TG 
myocytes versus TAC-induced upregulation of CaMKIIδ 
expression (Figure III in the Data Supplement).
To further test whether CaMKIIδC alone, in the 
absence of CaMKIIδB, can cause robust perinuclear 
accumulation of active CaMKII, we examined KO-δCTG. 
Figure 5E shows that 5-minute pacing at 5 Hz in these 
KO-δCTG myocytes caused prominent perinuclear 
CaMKIIδC and P-CaMKIIδC accumulation, which was 
prevented by preincubation with KN-93 (Figure 5G). 
Thus CaMKIIδC does not rely on CaMKIIδB to promote 
the pacing-induced nuclear and perinuclear CaMKII 
activation.
Finally, we overexpressed GFP (green fluorescent 
protein)–tagged WT CaMKIIδC and a P-CaMKII–
mimetic CaMKIIδC-T287D mutant. Notably, the auto-
phosphorylation-mutant was more nuclear (1.5-fold in 
the nucleoplasm and 1.2-fold on the NE), suggesting 
that CaMKIIδC activation indeed directs its nuclear local-
ization (Figure 5F).
Pacing-Dependent Nuclear HDAC4 Export in 
Young CaMKIIδC Transgenic Mice
The higher levels of nuclear and perinuclear active 
CaMKII would be expected to promote HDAC4 nuclear 
export. Figure 6A shows HDAC4 localization in quiescent 
young (6–8 weeks) WT, CaMKIIδC-TG, CaMKIIδ-KO, 
and KO-δCTG mice. At baseline, the CaMKIIδC-KO 
versus WT exhibits higher nuclear HDAC4 compared 
with cytosolic and perinuclear levels (FNuc/FCyto and FNuc/
FPN; Figure 6B), consistent with the KO preventing a 
baseline level of CaMKIIδ-dependent HDAC4 nuclear 
export. Conversely, CaMKIIδC overexpression without 
CaMKIIδB (KO-δCTG) reduced baseline nuclear HDAC4, 
expressed relative to either cytosolic or perinuclear, com-
pared to WT (Figure 6B). So CaMKIIδC by itself can drive 
nuclear export of HDAC4. Straight CaMKIIδC-TG mice 
(which also have CaMKIIδB) showed higher FNuc/FPN but 
not FNuc/FCyto. Conceivably, CaMKIIδB limits the baseline 
effect of CaMKIIδC on HDAC4, as has been suggested 
with respect to ischemia/reperfusion damage.8
High-pacing frequency drove time-dependent 
HDAC4 nuclear export in WT mice, which was acceler-
ated in TG mice, and prevented in KO mice (Figure 6C 
through 6E). Of note, there is a temporary retention of 
exported HDAC4 in the perinuclear region, evidenced 
by an increase in FPN/FCyto peaking at ≈10 min in TG, 
which was smaller and later in WT (Figure 6F). Although 
the FNuc/FCyto declined continuously throughout the 
pacing protocol and reached similar values in WT and 
TG mice at 25 to 30 minutes (Figure 6E and 6F), the 
perinuclear retention of HDAC4 was prominent earlier 
but also dissipated faster in TG mice. This could result 
from the faster rate of HDAC4 export in TG and then 
consequently faster diffusion away from the perinuclear 
region. Faster movement of HDAC4 further throughout 
the cytosol could also slow the reversal of pacing (or 
GPCR [G-protein–coupled receptor] activation) induced 
HDAC4 nuclear derepression. To test this, we monitored 
the recovery of FNuc/FCyto upon reduction of pacing from 
5 to 0.5 Hz at 15 minutes (Figure 6G). There was much 
faster recovery of nuclear HDAC4 in the WT than TG 
within 15 minutes (70 versus 20%). Thus, short-term 
accumulation of HDAC4 in the perinuclear region can 
allow faster reversal of transcriptional effects that are 
controlled by HDAC4 nuclear export.
To confirm our observations regarding HDAC4 trans-
location in real-time live-cell imaging, we used ventricular 
myocytes in which GFP-tagged HDAC4 was expressed 
via adenovirus (Figure 6H through 6J). Pacing here was 
at only 1.5 Hz (due to use of cultured myocytes), and that 
may explain the slower overall nuclear HDAC4 export; 
however, we still detected significant perinuclear accu-
mulation at this pacing rate (Figure 6H). Our related work 
demonstrating nuclear InsP3R and CaMKII involvement 
in GPCR-triggered HDAC5 nuclear export did not detect 
nuclear export in rabbit ventricular myocytes in response 
to 0.5 to 1 Hz stimulation.19 Thus, rapid nuclear HDAC 
export that is driven solely by CaTs may require high-
pacing rates (as implicit in Figure 6G).
These findings are in agreement with our subcellular 
Ca2+ and HDAC4 data upon pressure overload. Namely, 
in the early TAC at baseline CaMKIIδC appears to be 
involved in enhancement of cytoplasmic and particu-
larly nucleoplasmic CaTs (Figure 1), without changes in 
HDAC4 localization (Figure VI in the Data Supplement). 
In late TAC, CaMKIIδC is already accumulated in the 
nucleus and has a prominent role in ETC, as evidenced 
by reduced levels of nuclear HDAC4 at baseline (Figure 
VI in the Data Supplement). Collectively, our data sug-
gest that CaMKIIδC might play a dual role in the early 
phase after TAC; (1) CaMKIIδC primarily regulates the 
ECC, and, thus, promotes survival under baseline condi-
tions (Figure 1A through 1I and Figure VII in the Data 
Supplement), whereas (2) under stress, it translocates to 
the nucleus (Figure 5) and stimulates the ETC (Figure 6).
CaMKII Activation Versus Nuclear Translocation 
Determines Myocytes Genetic Profile
To further test whether the intensity of nuclear CaM-
KII activation differentially modulates pathological gene 
expression profiles, we used neonatal rat ventricular 
cardiomyocytes with pacing protocols that we found to 
induce similar increases in time-averaged [Ca2+]i as in 
early TAC mice or 6- to 8-week old CaMKIIδC-TG mice 
at high-pacing rates in Figure 4E. Neonatal rat ventricu-
lar cardiomyocytes stimulated at 8 Hz for 3 hours pro-















Ljubojevic-Holzer et al Perinuclear CaMKIIδC in Early and Late Hypertrophy
1170  October 9, 2020 Circulation Research. 2020;127:1159–1178. DOI: 10.1161/CIRCRESAHA.120.316947
Figure 6. HDAC4 (histone deacetylase) redistribution and high-pacing frequency-dependent translocation in electrically 
stimulated ventricular myocytes isolated from 6- to 8-wk old CaMKIIδ-KO (Ca2+-Calmodulin dependent protein kinase δ 
knockout), wild-type (WT) and mice with transgenic overexpression of CaMKIIδC in WT or KO background.
A, Original confocal images of cardiomyocytes from 6- to 8-wk old CaMKIIδ-KO (KO), WT, and mice with transgenic overexpression of CaMKIIδC 
in WT (TG) or KO (KO-TG) background immunostained for HDAC4. B, Corresponding subcellular distribution calculated as nucleo-to-cytoplasmic 
(left) or nucleo-to-perinuclear region (PN, right) fluorescence ratio (FNuc/FCyto and FNuc/FPN). Scale bar=20 μm. C, Representative images of HDAC4 
nu (FNuc/FCyto and FNuc/FPN) clear translocation in response to high-frequency stimulation (5 Hz) in cardiomyocytes isolated from 6- to 8-wk old TG 
mouse hearts, detected by immunostaining. Scale bar=10 μm. Contrast is enhanced to 1% saturation for better visualization of HDAC4-rich regions. 
D, HDAC4 redistribution in response to high-pacing frequency (5 Hz, 15 min) in cardiomyocytes isolated from WT, KO, and TG mice at 6–8 wk of age. 
B–D, n=70–80 myocytes per group. Pacing-induced time-dependent HDAC4 nuclear export calculated as (E) nucleo-to-cytoplasm or (F) PN-to-
cytoplasm region fluorescence ratio in ventricular myocytes isolated from 6- to 8-wk old CaMKIIδ-KO (KO, white), WT (gray) and CaMKIIδC-TG (TG, 
black) mice. G, HDAC4 nuclear reentry after cessation of high pacing calculated as nucleo-to-cytoplasm fluorescence ratio in ventricular myocytes 
isolated from 6- to 8-wk old CaMKIIδ-KO (KO, white), WT (gray), and CaMKIIδC-TG (TG, black) mice. n=9–17 myocytes per group. H, Representative 
confocal images of cultured adult cardiomyocyte infected with HDAC4-GFP (green fluorescent protein), paced at 1.5 Hz for 0, 15, or 30 min. Scale 
bars=20 μm for the whole cell and 10 μm for the zoomed nucleus. Time course of HDAC4 translocation is measured as (I) (I) nucleo-to-cytoplasmic 
(Nuc/Cyto) or (J) nucleo-to-perinuclear fluorescence ratios in response to low (gray) or high (green) pacing frequency. n=8–10 cells per group. P 
values were calculated using Kruskal-Wallis with Dunn post hoc test (B, and genotypes in D), Mann-Whitney test comparing 5 Hz and 0.5 Hz (D), or 
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CaMKII accumulation (Figure VIIA through VIIC in the 
Data Supplement). An intriguing aspect of these results 
is that CaMKII inhibition with KN-93 at the early TAC/
TG mimicking condition (8 Hz) promoted the largest 
myocyte hypertrophy and expression of NppB and inter-
leukin-6 receptor (IL6R). This hints that perhaps CaMKII 
activation in this condition is positively adaptive11 perhaps 
because of the enhanced SR Ca2+ uptake that prevents 
nuclear Ca2+ overload (Figures 1 through 3), at least for 
brain natriuretic peptide (BNP) and IL6R expression.
Pushing [Ca2+]i further by raising [Ca
2+]o to 3 mmol/L 
(mimicking more the 11-–13-week TG) resulted in 
robust enhancement of nuclear CaMKII and increased 
myocyte size (Figure VIID in the Data Supplement). This 
was also accompanied by transcriptional upregulation 
of well-established marker genes linked to pathological 
hypertrophy: NppB (BNP), RCAN-1, IL6R, and trans-
forming growth factor (TGF)-β1 (Figure VIIE in the Data 
Supplement). Notably, the RCAN-1 and TGF-β1 upregu-
lation was prevented by CaMKII inhibitor KN-93, under-
scoring the important role of nuclear CaMKII activation in 
this pathological progression.11 Indeed, TGF-β has been 
reported to have a prominent role in advanced stage of 
pressure overload, and its suppression in cardiomyocytes 
is protective against maladaptive cardiac remodeling.20,21
Increased CaMKIIδC Activation, and (Peri)
Nuclear Accumulation Promotes Eccentric 
Cardiac Hypertrophy
We next analyzed structural changes seen during the 
progressive hypertrophy in WT, KO, and transgenic mice 
overexpressing CaMKIIδC in WT (TG) or the CaMKIIδ 
null background (KO-δCTG). CaMKIIδ KO mice showed 
no statistical difference to WT in nearly all parameters 
measured in Figure 7 (including heart weight, lung weight, 
myocyte, and nucleus dimensions) for both young and 
older mice. The only difference was a minor reduction in 
cell width in the KO versus WT mice in young animals.
High levels of CaMKIIδC found in both CaMKIIδC-TG 
and KO-δCTG mouse lines (around 7-fold increase over 
endogenous CaMKII, Figure IIIA in the Data Supple-
ment) could induce nonspecific cellular distributions and 
unspecific kinase effects. Our previous work confirmed 
that overexpressed CaMKIIδC was similarly distributed 
among cytosolic, mitochondrial, SR, and nuclear fractions 
as for endogenous CaMKIIδC, even when CaMKIIδC 
was expressed in the KO background.6 In addition, at 
the sarcomeric level, both endogenous and overex-
pressed CaMKIIδ are highly concentrated at the Z-line, 
with additional midsarcomere and nuclear signal.7 This 
is consistent with the well-documented association of 
CaMKII with RyR2 located at the SR. This sarcomeric 
profile of CaMKIIδ was seen in our immunofluorescent 
images of WT, TG, and KO-δCTG ventricular myocytes 
(Figure IIIC in the Data Supplement). Also, perinuclear 
CaMKII at baseline in WT mice was uniform throughout 
the nucleus, TG mice had comparable level intranuclear, 
but higher at the NE, whereas KO-δCTG mice showed 
low nucleoplasmic signal (due to the loss of CaMKIIδB) 
and prominent NE signal, as in TG mice. Most impor-
tantly, transgenically overexpressed CaMKIIδC behaves 
functionally much like the TAC-induced overexpressed 
CaMKIIδC with respect to nuclear translocation that also 
drives hypertrophy.
Both CaMKIIδC transgenic mice, CaMKIIδC-TG and 
KO-δCTG, showed cardiac hypertrophy resulting in the 
development of HF (Figure 7A and 7B). Although the 
extents of CaMKIIδC overexpression was not statistically 
different (Figure III in the Data Supplement), KO-δCTG 
mice showed remarkably accelerated remodeling and 
transition to HF compared to TG mice, as evidenced by 
a larger and earlier increases in heart weight-to-body 
weight ratio and signs of pulmonary edema (Figure 7A 
and 7B). In addition, KO-δCTG cardiomyocytes showed 
exclusively eccentric growth, with a large increase in cell 
length but unaltered cell width over time (Figure 7C and 
7D). TG myocytes exhibited balanced concentric-eccen-
tric growth, such that myocyte length/width ratio was 
unaltered at 6 to 8 weeks and only minimally increased 
at weeks 11 to 13 (compared with WT). Different modes 
of myocyte growth resulted in an increase in ventricular 
wall thickness without chamber enlargement in young TG 
mice (concentric hypertrophy),13 whereas cell lengthen-
ing promoted chamber dilatation with severely depressed 
cardiac function, already in 6- to 8-week old KO-δCTG 
mice.8 KO-δCTG mice also showed high early mortality 
and shorter lifespan compared with TG mice, and with 
aging, these mice exhibited extreme dilatory growth. Fig-
ure 7E and 7F shows that nuclear growth followed simi-
lar pattern of length-width ratios as the myocyte growth, 
and could relate to a role for changed NE structure in 
promoting cardiac pathology.4
CaMKIIδC Activation and (Peri)Nuclear 
Accumulation Is a Hallmark of HF
We had access to nonfailing and failing human myo-
cardium to perform comparative analyses of CaMKIIδ 
expression in TAC mice and in human HF tissue and 
nuclear fractions (Figure 8). The enrichment of selected 
fractions was confirmed by using additional markers of 
cellular compartments (eg, Na+/K+-ATPase for plasma 
membrane and Nup62 for nuclear membrane) and con-
focal imaging of purified nuclear fraction (Figure VIII in 
the Data Supplement). Western blots with left ventricu-
lar tissue lysates (Figure 8A and 8B and 8E and 8F) 
and isolated cardiomyocyte nuclei (Figure 8C and 8D 
and 8G and 8H) revealed a large increase of CaMKIIδ 
expression in both tissue and isolated nuclear fractions 
in failing versus nonfailing hearts. The large increase in 
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Figure 7. Characterization of hypertrophic growth of the heart, cardiomyocytes, and nuclei in 6–8-wk and 11–13-wk old 
CaMKIIδ-KO (Ca2+-Calmodulin dependent protein kinase δ knockout), wild-type (WT) and mice with transgenic overexpression 
of CaMKIIδC in WT or KO background.
A, Photomicrographs of hearts taken at age 6–8 wk (top) and 11–13 wk (bottom). Scale bar is 5 mm. B, Heart weight or lung weight 
normalized to body weight. N=5–18 per group. C, Original 2-dimensional (2D) images of cardiomyocytes isolated from CaMKIIδ-KO (KO), WT, 
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to be due to the accumulation of CaMKIIδC isoform in 
the nuclear region (Figure 8C and 8D and 8G and 8H), 
underscoring the pivotal role of increased CaMKIIδC 
activation and (peri)nuclear accumulation in eccentric 
cardiac hypertrophy, both in mouse model and in failing 
human hearts.
DISCUSSION
Although CaMKIIδ has emerged as a promising target 
in cardiac remodeling over the past 2 decades,22–25 more 
nuanced understanding of its splice variants and acti-
vation state regulation is required for more precision 
targeting.6,26,27 Here, we provide compelling evidence 
for the critical role of CaMKIIδC activation, secondary 
to very early enhancement of cytoplasmic and espe-
cially nucleoplasmic Ca2+ signaling in a mouse model 
of pressure overload and in failing human hearts. This 
enhanced Ca2+ signaling further promotes CaMKIIδC 
activation, leading to its (peri)nuclear accumulation and 
promotion of eccentric cardiac growth. The autorein-
forcing property of CaMKIIδC signaling, via interplay 
between ECC and ETC, is critical for the progression of 
cardiac hypertrophy to HF.28
Remarkable Parallelism in Early TAC and Early 
CaMKIIδC Transgenic Mice
CaMKIIδC expression is selectively increased as early 
as one day post-TAC.13,29 What struck us here was the 
remarkable parallelism of changes observed in early TAC 
(5 days) and early CaMKIIδC-TG mice (6 to 8 weeks) 
before any overt pathological effects. Indeed, at this 
stage in both groups the CaT amplitude, rate of [Ca2+]i 
decline and SR Ca2+ content were all increased, espe-
cially at the nucleus. Additionally, PLB phosphorylation 
was increased, its expression was reduced, especially 
near the nucleus, in both models (in line with enhanced 
SERCA function as observed here as faster twitch [Ca2+]i 
decline). Early CaMKIIδ TG mice also exhibited nuclear 
remodeling as did 1-week post-TAC in our prior study.4 
CaMKII was also more concentrated in the nuclear/peri-
nuclear region and more activated in both models, and 
both early models already showed increased HDAC4 
nuclear export. The fact that early CaMKIIδC overex-
pression can recapitulate the same tableau of effects 
as early TAC (including the CaMKII activation) raises the 
possibility that TAC-induced CaMKII activation may be 
an early compensatory response that boosts myocyte 
CaTs and contractility to meet the imposed afterload. 
Indeed, we show that the extent of nuclear CaMKII acti-
vation correlates with activation of gene expression of 
selected well-known remodeling marker genes in neo-
natal rat ventricular cardiomyocytes. This was most clear 
for RCAN-1 and TGF-β1, where KN-93 also prevented 
the Ca-dependent effects. However, for NppB and IL6R, 
CaMKII inhibition exacerbated the rise in gene expres-
sion, suggesting increased complexity. One possibility is 
that the beneficial side of CaMKII activation seen in early 
TAC and CaMKIIδC-TG might also restrain somehow the 
induction of NppB and IL6R.
As both TAC and CaMKIIδC-TG mice age further they 
progress to major cardiac hypertrophy and transition to 
HF with lung congestion, greatly reduced ejection frac-
tion and reduced myocyte CaT amplitudes with slowed 
[Ca2+]i decline (at 6–7 weeks for TAC and 11–13 weeks 
in CaMKIIδ TG). Notably, as mice in both of these models 
develop HF, the time-averaged nuclear [Ca2+] and (peri)
nuclear CaMKII level and activity is further enhanced 
which may reinforce the nuclear CaMKII and HDAC4 sig-
naling and their sequelae. This chronic CaMKII activation 
in the HF stage may no longer be compensatory but may 
progress to being maladaptive, as indicated by prominent 
CaMKIIδ- and RyR-dependent SR Ca2+ leak that can be 
proarrhythmic and reduce SR Ca2+ content.12,30 Chronic 
CaMKIIδ activation in HF can alter the function of many 
ion channels in ways that worsen function and promote 
arrhythmias.5,31 Indeed, CaMKIIδ-KO mice are particu-
larly protected in the transition from compensated hyper-
trophy to overt HF, and this includes a dramatic limitation 
in the development of cardiac fibrosis.21,28
Enhanced SR and NE Ca2+ Stores in Early TAC 
and CaMKIIδ TG Mice
The amplitude of caffeine-evoked cytoplasmic and 
nucleoplasmic CaTs were both increased in TAC mice, 
but the relative increase was larger in the nucleus, sug-
gesting differential regulation of NE versus SR Ca2+ load 
in early remodeling. Indeed, although SERCA2 expres-
sion was unchanged in either nuclear or cytoplasmic 
compartment, PLB expression was decreased in both 
subcellular spaces, and most dramatically in the nuclear 
compartment. Consequently, the SERCA/PLB ratio was 
most evidently increased in the nuclear fraction. Wu et 
al16 recently showed that PLB is especially concentrated 
at the NE, and our myocyte immunostaining and fraction-
ation studies confirm that (Figure 3). However, following 
TAC or upon transgenic CaMKIIδC overexpression the 
PLB levels around the nucleus dropped markedly, largely 
Figure 7 Continued. immunostaining for total-CaMKII. Scale bar=20 μm. D, Cardiomyocyte dimensions (top), cell length-to-width ratio, and cell 
length in conjunction with cell width (bottom). n=100–500 cells per group. E, Original 2D images of cardiomyocytes isolated from CaMKIIδ-KO 
(KO), WT, and mice with transgenic overexpression of CaMKIIδC in WT (TG) or KO (KO-TG) background at 11–13 wk following DAPI staining 
for visualization of nuclei. Scale bar=20 μm. F, Nucleus dimensions (top), nucleus length-to-width ratio, and nucleus length in conjunction with 
nucleus width (bottom). n=100–500 nuclei per group. Indicated. P values were calculated using Kruskal-Wallis with Dunn post hoc test. BW 
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eradicating the apparent NE/SR PLB/SERCA2 ratio. 
This downregulation of PLB in CaMKIIδC-TG cardiomy-
ocytes was previously reported,12 but here we show that 
this is especially true around the nucleus. Although PLB 
expression is typically reduced and its phosphorylation is 
enhanced in HF, the mechanism of PLB downregulation 
is not understood. It has been recently shown that PLB is, 
at least partially, oligo-ubiquitinated at Lys3 and degraded 
through phosphorylation-mediated polyubiquitination 
during HF.32 As PLB is overproportionally phosphory-
lated around nucleus, this negative feedback mechanism 
may well be responsible for preferential decrease in PLB 
levels around nucleus. The predominant reduction of 
PLB levels around nucleus may contribute to the higher 
nuclear/perinuclear [Ca2+]i levels observed here, which 
may promote both higher local CaMKII activation as well 
as higher net HDAC4 phosphorylation by CaMKII, a pro-
cess known to mediate nuclear export of HDAC4 and 
derepression of Mef2-dependent transcription.33
Perinuclear CaMKII and HDAC4 as a New Local 
Signaling Microdomain
The perinuclear region (PN) may indeed be a key micro-
domain for exactly this type of signaling. Our previous 
work suggested that NE SERCA pumps are mainly on 
the outer leaflet and that most RyR2 channels are in the 
nearby SR membrane but largely excluded from the NE,4 
despite the fact that the NE membranes (and lumen) are 
continuous with that of the SR.19 This means that normal 
nuclear CaTs are mainly driven by Ca2+ release from 
near-nuclear RyR and diffusion through nuclear pores,10 
and that [Ca2+]Nuc decline requires diffusion back out of 
the nucleus to be re-sequestered via NE/SR SERCA2 
pumps. The higher Ca2+ fluxes through this very region, 
as suggested by the data presented here, may poise this 
system for dynamic Ca2+ signaling that influences CaM-
CaMKII and CaM-calcineurin signaling and translocation 
across the NE.
The Ca2+-related microdomain described above may 
also encompass the large mAKAP (muscle A-kinase 
anchoring protein) signaling complex that is localized 
just outside the NE and includes PKA (protein kinase 
A) and calcineurin.34 Together this PN microdomain 
may tune the signals (and molecules) that get into the 
nucleus to influence gene transcription and also create 
a local buffering environment for some of these mole-
cules, keeping them available for import upon demand. 
This is precisely what we hypothesize for the perinuclear 
accumulation of HDAC4 that we observed in Figure 6F. 
That is, the acute HDAC4 nuclear export observed upon 
CaMKII activation could be sustained by high PN CaM-
KII activity (to rephosphorylate any exported HDAC4 that 
happens to get dephosphorylated), thereby maintaining 
nuclear HDAC4 depletion. Then, once the CaMKII signal 
is reduced, this local pool of HDAC4 can quickly reen-
ter the nucleus to help turn off the transcriptional switch. 
Having some of this HDAC4 remain local may speed this 
turn off compared to what would occur if all the exported 
Figure 8. Expression of CaMKIIδ (Ca2+-Calmodulin dependent protein kinase δ) in tissue lysates vs isolated cardiomyocyte 
nuclei from nonfailing and failing human hearts.
A, Western blots and (B) average data of CaMKIIδ and P-CaMKII (phospho-CaMKII) expression in tissue lysates from sham (S) and early (5–7 
d, TE) and late (3–6 wk, TL) transaortic constriction (TAC)–operated mice. C, Western blots and (D) average data of CaMKIIδ expression in 
isolated nuclei from S and TL TAC-operated mice. A and B, N=4 mice per group. C and D, pool of N=6 mice per group in 3 technical replicates, 
GAPDH and H3 were used as loading control for tissue lysate or nuclei samples, respectively. E, Western blots and (F) average data of CaMKIIδ 
expression in tissue lysates and (G and H) isolated nuclei from nonfailing and failing human hearts. Gapdh and H3 were used as loading control 
for tissue lysate or nuclei samples, respectively. N=8–10 per group; 4 technical replicates. P values were calculated using ANOVA with Dunnett 
post hoc test (B), Mann-Whitney test comparing TAC or F to the respective control, or Wilcoxon signed-rank test for paired δC vs δB comparisons 
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HDAC4 went to the far reaches of the cytosol (as in 
Figure 6G).
Frequency- and GPCR-Induced Changes in 
[Ca]Nuc versus [Ca]Cyto
Here and elsewhere4,10 we have highlighted that simply 
increasing stimulation frequency preferentially promotes 
nuclear Ca2+ accumulation, as a consequence of the 
slower decline of the nuclear versus cytosolic CaTs, and 
consequent rising of diastolic and time-averaged [Ca]Nuc. 
That by itself can promote Ca2+-dependent activation of 
nuclear signaling (eg, via CaMKII, as shown here). How-
ever, physiologically higher heart rates are accompa-
nied by β-adrenergic receptor activation which (via PKA 
effects on Ca2+ current and SR Ca2+ uptake) further 
increase the CaT amplitude and perforce drive harder 
the Ca2+-CaMKII signaling described here. In addition, 
the relative paucity of PLB at early times of TAC and in 
CaMKIIδ TG mice would limit the PKA-dependent accel-
eration of local PN [Ca2+]i decline. Notably, PKA can also 
phosphorylate HDAC4/5 and favor their nuclear local-
ization,35,36 and the resultant effect of these multiple 
factors on HDAC translocation and transcription merits 
further study.
Higher quantitative effects in systems that are inher-
ently integrative (like CaMKII activation and transloca-
tion) may be expected to recruit different qualitative 
responses such as CaT kinetics versus gene expression 
over time, depending upon extent and location of activa-
tion and kinetics of responses. Thus, we posit that the 
more limited, and kinetically reversible CaMKII activation 
at the perinuclear and SR domains may allow CaMKII 
to have beneficial adaptive effects on the amplitude and 
kinetics of CaTs to cause enhanced contraction to meet, 
in the case of TAC, a greater cardiac afterload. Indeed, 
CaMKII inhibition prevents the acute increase in CaTs in 
cells embedded in an afterload-inducing 3-dimensional 
gel.37 However, as the extent of CaMKII activation gets 
stronger and more chronic (eg, by autophosphorylation, 
oxidation, or S-nitrosylation) inside the nucleus (rather 
than just around it) and reinforced by higher nuclear 
[Ca2+], this can promote qualitative changes in gene tran-
scription, assessed here by HDAC4 nuclear export and 
transcriptional activation of TGF-β1. And those changes 
in gene expression may undercut the short-term com-
pensatory CaMKII effects on CaTs, which we know are 
lost in end-stage HF where SERCA function and CaTs 
are typically depressed.2
Gq-protein coupled receptors targeted by angioten-
sin II, endothelin-1, and α-adrenergic agonists tend to 
be activated as part of the neurohumoral storm associ-
ated with hypertrophic and HF signaling.38 These ago-
nists activate CaMKII and PKD (protein kinase D) and 
promote HDAC4/5 nuclear export. Part of this effect is 
caused by InsP3 which promotes release of Ca
2+ directly 
from the NE into the nucleoplasm and PN space.16,39–41 
We previously showed how the additional activation of 
nuclear InsP3 receptors can greatly amplify the nuclear 
(and PN) Ca2+ signals induced by pacing, and that drive 
CaMKII activation, HDAC4 nuclear export, and hyper-
trophic gene signaling.4 We speculate that the compen-
satory stage seen early in both TAC and CaMKIIδC-TG 
mice may provide adaptive advantage and that some tip-
ping point is eventually reached, perhaps in response to 
elevated Gq-coupled receptor activation, that transitions 
the compensatory adaptive stage to one that is mal-
adaptive in terms of both CaMKII activation levels and 
transcriptional signaling. Although this is an attractive 
hypothesis, understanding the impact of neurohormonal 
stimulation on perinuclear trafficking under a range of 
physiological pacing rates requires further investigation.
CaMKIIδC Versus CaMKIIδB in Driving 
Pathology
Experiments in myocytes from CaMKIIδC-TG mice in WT 
versus CaMKIIδ null background revealed that (1) the 
predominant splice variant responsible for the dispropor-
tionate P-CaMKII levels in the NE region is CaMKIIδC, 
and (2) the effect is not the result of higher CaMKIIδC 
expression, but rather redistribution of more active 
CaMKIIδC towards the nucleus and NE. Although CaM-
KII has been thought to be anchored in cardiomyocytes, 
Wood et al7 demonstrated that CaMKII is highly mobile in 
adult ventricular myocytes even at rest and that its mobil-
ity is further enhanced by CaTs and its activation state.
To address downstream functional effects of perinu-
clear CaMKIIδC upregulation, we assessed HDAC4 trans-
location. Remarkably, overexpression of CaMKIIδC alone 
(KO-δCTG) induced baseline nuclear HDAC4 export even 
in the absence of CaMKIIδB. Moreover, the presence of 
CaMKIIδB in CaMKIIδC-TG mice (at the same overall 
level of CaMKIIδ and P-CaMKIIδ as in KO-δCTG; Figure 
III in the Data Supplement) did not cause net reduction 
in baseline nuclear HDAC4 export (based on FNuc/FCyto in 
Figure 6B). Thus, CaMKIIδC strongly promotes HDAC4 
to shift from nucleus to cytosol, and CaMKIIδB may limit 
that. In line with this hypothesis, we could show that in the 
absence of CaMKIIδC (ie, in CaMKIIδB transgenic mice 
in KO background), overexpression of CaMKIIδB, failed to 
exhibit similar effects on cardiac hypertrophy or function 
(Figure IX in the Data Supplement). Moreover, in line with 
more recent studies on CaMKIIδB mice, demonstrating 
that this nuclear splice variant exhibits cardioprotective 
effects,8,42 we found a milder phenotype of CaMKIIδC-TG 
mice in WT versus in KO background, and in CaMKIIδC-TG 
mice in KO versus WT background (Figure 7 and Figure 
IX in the Data Supplement).
However, both TG mice showed reduced FNuc/FPN 
HDAC4 ratio at baseline versus WT, suggesting that 
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localization around the NE. In contrast, CaMKIIδ KO 
elevated nuclear-to-cytoplasmic HDAC4 ratio, confirm-
ing that baseline CaMKIIδ may suffice to drive some 
HDAC4 out of the nucleus. Importantly, the pacing-
induced HDAC4 nuclear export was accelerated even in 
young asymptomatic CaMKIIδC-TG mice. Because it is 
well established that prolonged translocation of HDAC4 
out of the nucleus relieves the suppression of hypertro-
phic gene programming leading to adverse cardiac phe-
notype,18,33 this effect is expected to have pathological 
consequences.
Although no major cardiac dysfunction was seen in 
early (8 weeks) CaMKIIδC-TG mice, at 11 to 13 weeks, 
they exhibited massive hypertrophy and lung congestion 
(Figure 7A and 7B), major reductions in fractional short-
ening, and premature death.13 To complement in vivo 
function measurements in TG13 and KO-δCTG8 mice, 
we also assessed cellular and nuclear dimensions in WT, 
KO, TG, and KO-δCTG mice. Although both CaMKIIδC 
transgenic mouse lines exhibited hypertrophic cardiac 
growth which progressed to HF, KO-δCTG mice showed 
accelerated remodeling as evidenced by more severe 
phenotypes at each stage. Also, the KO-δCTG mice dis-
played exclusively eccentric growth of both myocyte and 
nuclear length, whereas TG cardiomyocytes (with endog-
enous CaMKIIδB) showed more balanced concentric 
and eccentric growth, with preserved myocyte length/
width ratio at the age of 6 to 8 weeks and only mini-
mally increased at weeks 11 to 13 (Figure 7C through 
7F). Those findings suggest that CaMKIIδC especially 
promotes eccentric cardiomyocyte growth, whereas 
CaMKIIδB may preferentially drive concentric hyper-
trophy or help to ensure balanced eccentric-concentric 
growth. This is a strong argument for a more deleteri-
ous role for CaMKIIδC versus CaMKIIδB in promoting 
adverse cardiac remodeling. This agrees with observa-
tions on the whole heart level, where CaMKIIδB-TG mice 
primarily develop cardiac hypertrophy whereas hypertro-
phy in the CaMKIIδC-TG mice is more dilated and rapidly 
transitions to HF.18,43 In addition, Grey et al8 observed that 
KO-δBTG mice had normal survival for at least 6 months, 
whereas KO-δCTG died prematurely with <20% survival 
by 21 weeks. Moreover, CaMKIIδB and δC variants had 
strikingly different effects on in vivo cardiac function; in 
6- to 8-week-old KO-δCTG mice, fractional shortening 
was decreased by 63% compared to WT littermates while 
KO-δBTG mice showed no signs of cardiac dysfunction.
Human Data and Clinical Relevance
Our human HF data confirm the widely reported CaMKIIδ 
upregulation in human HF,22,24,30 but here, we demon-
strate that this is true also in the nuclear fraction and 
that the CaMKIIδC splice variant increases most dra-
matically. Thus, we conclude that the same pathological 
concentration of CaMKII to the nuclear domain that we 
demonstrate in mouse is occurring in human HF as well, 
with the δC splice variant being the key culprit.
One caveat here is that while CaMKIIδB and δC (also 
known as δ3 and δ2, respectively) are major CaMKIIδ 
transcripts in mouse, Zhang et al27 recently reported 
that a longer CaMKIIδ9 mRNA product is especially 
prominent and pathological in humans. They found that 
CaMKIIδ9 mRNA is expressed at levels similar to those 
of CaMKIIδB in mouse and human hearts and that 
CaMKIIδ9 disrupts DNA repair causing genome instabil-
ity and myocyte death. We cannot rule out that CaMKIIδ9 
expression contributes to the upper CaMKIIδ band 
(labeled δB in Figure 8C) because CaMKIIδ9 protein is 
only 3 amino acids longer than δB. However, it is a less 
likely contaminant of the highly increased CaMKIIδ band 
labeled δC in Figure 8C since CaMKIIδ9 is 14 amino 
acids longer than δC. The role of this isoform in perinu-
clear Ca signaling and HDAC redistribution merits future 
examination.
Taken together, our data indicate that increase in 
nuclear and perinuclear CaMKIIδC activation is a very 
early cellular response to pressure overload. Moreover, 
this CaMKII activation causes an adaptive compensatory 
TAC-induced enhancement of Ca2+ transients, as indi-
cated by the finding that it is abolished acutely by CaM-
KII inhibition (Figure 1H). The concomitant enhancement 
of nuclear Ca2+ transients and time-averaged [Ca]Nuc, in 
turn, further activate CaMKIIδC, causing its (peri)nuclear 
accumulation and HDAC4 nuclear export. Prolonged 
HDAC4 nuclear export likely promotes the hypertrophic 
gene program at the transcriptional level, and this may 
be amplified by CaMKIIδ-dependent phosphorylation 
at S10 on histone H3, which also occurs early in TAC.44 
This early phase of CaMKIIδ activation may indeed be 
beneficial and helps promote adaptive functional com-
pensation, but in the long run, we hypothesize that this 
chronic CaMKII activation becomes a part of the mal-
adaptive progression toward HF (including effects on 
Ca2+ handling, ion channels, inflammation, fibrosis, and 
interaction with other pathways). So, selective inhibition 
of CaMKIIδC (or δ9) or HDAC nuclear export may be 
beneficial, especially in later HF stages.
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